ReportsnReports: Hepatitis Market to 2017 - Strong Hepatitis-C Pipeline, Large Number of Strategic Consolidations and Cost Effective Treatments
06-Jan-2012 | News-Press Release
GBI Research’s new report, “Hepatitis Market to 2017 – Strong Hepatitis-C Pipeline, Large Number of Strategic Consolidations and Cost Effective Treatments will Drive the Market”, provides in-depth analysis of the unmet need, drivers and barriers impacting the global hepatitis market. The report analyzes the hepatitis markets in the US, the top five countries in Europe (the UK, Germany, France, Italy and Spain) and Japan. Treatment usage patterns, sales, prices and volumes are forecast until 2017 for the key geographies as well as the leading therapeutic segments. The report also provides competitive benchmarking for the leading companies and analyzes the mergers, acquisitions and licensing agreements that have shaped the global markets.
This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GBI Research’s team of industry experts.
Request a Sample for or Inquire before buying the report @
http://www.reportsnreports.com/reports/144351-hepatitis-market-to-2017-strong-hepatitis-c-pipeline-large-number-of-strategic-consolidations-and-cost-effective-treatments-will-drive-the-market.html
Scope
• Annualized market data for the hepatitis market from 2002 to 2010, forecast forward to 2017.
• Analysis of the leading segments, including hepatitis A, hepatitis B and hepatitis C.
• Analysis of the hepatitis market in the leading geographies of the world, which include the US, the UK, Germany, France, Italy, Spain and Japan.
• Market characterization of the hepatitis therapeutics market, including market size, annual cost of therapy and treatment usage patterns.
• Key drivers and barriers that have a significant impact on the market.
• Coverage of pipeline molecules in various Phases of drug development.
• Competitive benchmarking of leading companies. The key companies studied in this report are Merck & Co, GlaxoSmithKline and F. Hoffman-La Roche.
• Key M&A activities, licensing agreements that have taken place between 2009 and mid-2011 in the global hepatitis market.
About Us:
ReportsnReports is an online library of over 100,000+ market research reports and in-depth market research studies & analysis of over 5000 micro markets. We provide 24/7 online and offline support to our customers. Get in touch with us for your needs of market research reports.
Follow us on Twitter: http://twitter.com/marketsreports
Our Facebook Page: http://www.facebook.com/pages/ReportsnReports/191441427571689
Contact:
Mr.Priyank
7557 Rambler road,
Suite727,Dallas,TX75231
Tel: + 1 888 391 5441
E-mail: sales@reportsandreports.com
http://www.reportsnreports.com
Blog: http://www.reportsnreportsblog.com/
This release was submitted by a PRSafe user.
Any communication related to the content of this release should be sent to the release submitter.
Author Info
Tag Cloud
Categories
More Releases
- Vitamins and Provitamins - Top 5 European Markets
- 2012 Deep Research Report on China Special Steel Industry
- ReportsnReports: Emerging Opportunities and Growth Prospects in the Mexican Travel Intermediaries Industry, Analyses and Forecasts to 2016
- ReportsnReports - The Future of Italian Foodservice Industry to 2016
- ReportsnReports: Germany – The Future of HNWIs to 2016: Wealth in the Powerhouse of Europe
- ReportsnReports: 2012 Deep Research Report on China PV Power Station Operator
- ReportsnReports: The Future of Retailing in Chile to 2016
- ReportsnReports: Global Markets for Media, Sera and Reagents in Biotechnology
- ReportsnReports: Amusement Park Foodservice Trends in the U.S.
- ReportsnReports - Battery Control Technology: Global Markets